SAM
TMO icon

Storebrand Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Storebrand Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$108M Buy
214,598
+3,847
+2% +$1.85M 0.26% 77
2026
Q1 		$104M Sell
210,751
-3,514
-2% -$1.91M 0.3% 71
2025
Q4 		$124M Buy
214,265
+4,981
+2% +$2.82M 0.33% 60
2025
Q3 		$102M Buy
209,284
+2,110
+1% +$982K 0.27% 78
2025
Q2 		$84M Sell
207,174
-14,807
-7% -$6.19M 0.24% 84
2025
Q1 		$110M Sell
221,981
-7,800
-3% -$4.22M 0.36% 55
2024
Q4 		$120M Buy
229,781
+6,146
+3% +$3.38M 0.36% 47
2024
Q3 		$138M Buy
223,635
+4,969
+2% +$2.94M 0.44% 42
2024
Q2 		$121M Buy
218,666
+494
+0.2% +$283K 0.4% 47
2024
Q1 		$127M Sell
218,172
-1,273
-0.6% -$714K 0.43% 48
2023
Q4 		$116M Buy
219,445
+14,464
+7% +$7M 0.42% 49
2023
Q3 		$104M Sell
204,981
-587
-0.3% -$313K 0.49% 35
2023
Q2 		$107M Buy
205,568
+10,543
+5% +$5.69M 0.49% 38
2023
Q1 		$112M Buy
195,025
+224
+0.1% +$126K 0.57% 30
2022
Q4 		$107M Sell
194,801
-11,045
-5% -$5.85M 0.59% 27
2022
Q3 		$104M Buy
205,846
+132
+0.1% +$73.9K 0.63% 28
2022
Q2 		$112M Sell
205,714
-12,179
-6% -$6.7M 0.63% 28
2022
Q1 		$129M Sell
217,893
-4,879
-2% -$2.8M 0.61% 25
2021
Q4 		$149M Buy
222,772
+12,806
+6% +$8M 0.66% 21
2021
Q3 		$120M Buy
209,966
+4,283
+2% +$2.35M 0.59% 28
2021
Q2 		$104M Sell
205,683
-15,872
-7% -$7.49M 0.5% 37
2021
Q1 		$101M Buy
221,555
+5,546
+3% +$2.65M 0.54% 34
2020
Q4 		$101M Buy
216,009
+22,438
+12% +$10.5M 0.6% 30
2020
Q3 		$85.5M Buy
193,571
+4,734
+3% +$1.96M 0.61% 32
2020
Q2 		$68.4M Buy
188,837
+16,329
+9% +$5.47M 0.57% 32
2020
Q1 		$48.9M Buy
+172,508
New +$54.4M 0.51% 39

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Storebrand Asset Management's TMO Position: Q2 2026 in Review

Storebrand Asset Management increased its Thermo Fisher Scientific (TMO) stake by 1.8% in Q2 2026, buying an estimated $1.85M and bringing the position to 214,598 shares worth $108M. The position accounts for 0.26% of the portfolio, ranked #77.

Storebrand Asset Management first reported a position in TMO in Q1 2020 and has held it in 26 quarters since. The position peaked at $149M in Q4 2021. 2,508 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Storebrand Asset Management held 214,598 shares of Thermo Fisher Scientific worth $108M as of Q2 2026.
  • Storebrand Asset Management bought 3,847 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.85M.
  • Thermo Fisher Scientific made up 0.26% of Storebrand Asset Management's portfolio in Q2 2026, its #77 holding.
  • Storebrand Asset Management first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 26 quarters since.
  • Storebrand Asset Management's Thermo Fisher Scientific position peaked at $149M in Q4 2021.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Storebrand Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.